Sebastià González‐Peris

Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study

Ángela Domı́nguez, Pilar Ciruela, Sergi Hernández et al. · PLoS ONE · 2017 · 87 citations · Full text

Vaccine Failures in Patients Properly Vaccinated with 13-Valent Pneumococcal Conjugate Vaccine in Catalonia, a Region with Low Vaccination Coverage

F.A. Moraga Llop, Juan José García‐García, Alvaro Díaz‐Conradi et al. · The Pediatric Infectious Disease Journal · 2015 · 50 citations

Vaccination, Vaccine Safety, Vaccinology +14

Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2–59 Months of Age, Spain

Sergi Hernández, F.A. Moraga Llop, Álvaro Díaz et al. · Emerging infectious diseases · 2020 · 32 citations · Full text

Vaccine Failures, Pcv13 Serotypes, Immunodeficiencies +17

Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13‐valent pneumococcal conjugate vaccine era

Alvaro Díaz‐Conradi, Sergi Hernández, Juan José García‐García et al. · Pediatric Pulmonology · 2019 · 30 citations

Risk Factors for Severe Anaphylaxis in Children

Mikel Olabarri, Paula Vázquez, Aranzazu González‐Posada et al. · The Journal of Pediatrics · 2020 · 26 citations

Asthma, Allergy, Allergy Medicine +6